[The treatment of myelo-proliferative syndromes].
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001855:Bone Marrow Diseases / Q000628:therapy*; D006728:Hormones / Q000627:therapeutic use*; D006801:Humans; D007951:Leukemia, Myeloid / Q000628:therapy*; D009196:Myeloproliferative Disorders / Q000628:therapy; D010759:Phosphorus Isotopes / Q000627:therapeutic use*; D011087:Polycythemia Vera / Q000628:therapy*; D055728:Primary Myelofibrosis / Q000628:therapy*
D000970:Antineoplastic Agents; D006728:Hormones; D010759:Phosphorus Isotopes
Le traitement des syndromes myélo-prolifératifs.